TinderMIX: Time-dose integrated modelling of toxicogenomics data

Abstract Background Omics technologies have been widely applied in toxicology studies to investigate the effects of different substances on exposed biological systems. A classical toxicogenomic study consists in testing the effects of a compound at different dose levels and different time points. The main challenge consists in identifying the gene alteration patterns that are correlated to doses and time points. The majority of existing methods for toxicogenomics data analysis allow the study of the molecular alteration after the exposure (or treatment) at each time point individually. However, this kind of analysis cannot identify dynamic (time-dependent) events of dose responsiveness. Results We propose TinderMIX, an approach that simultaneously models the effects of time and dose on the transcriptome to investigate the course of molecular alterations exerted in response to the exposure. Starting from gene log fold-change, TinderMIX fits different integrated time and dose models to each gene, selects the optimal one, and computes its time and dose effect map; then a user-selected threshold is applied to identify the responsive area on each map and verify whether the gene shows a dynamic (time-dependent) and dose-dependent response; eventually, responsive genes are labelled according to the integrated time and dose point of departure. Conclusions To showcase the TinderMIX method, we analysed 2 drugs from the Open TG-GATEs dataset, namely, cyclosporin A and thioacetamide. We first identified the dynamic dose-dependent mechanism of action of each drug and compared them. Our analysis highlights that different time- and dose-integrated point of departure recapitulates the toxicity potential of the compounds as well as their dynamic dose-dependent mechanism of action.

[1]  Der-Shan Sun,et al.  Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice , 2019, Scientific Reports.

[2]  Marilyn J Aardema,et al.  Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. , 2002, Mutation research.

[3]  Hitoshi Iwahashi,et al.  Toxicogenomics using yeast DNA microarrays. , 2010, Journal of bioscience and bioengineering.

[4]  Mohammed Yahya Alomar,et al.  Effect of Basil Leaves Extract on Liver Fibrosis Induced by Thioacetamide in Male Rats , 2019, International Journal of Pharmacology.

[5]  Ana Conesa,et al.  Next maSigPro: updating maSigPro bioconductor package for RNA-seq time series , 2014, Bioinform..

[6]  Norbert Gretz,et al.  TTCA: an R package for the identification of differentially expressed genes in time course microarray data , 2017, BMC Bioinformatics.

[7]  Harvey J Clewell,et al.  A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  K. Oniki,et al.  The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease , 2016, Nutrition & Diabetes.

[9]  Rolf Altenburger,et al.  Map and model—moving from observation to prediction in toxicogenomics , 2019, GigaScience.

[10]  Jean Lou Dorne,et al.  EFSA Scientific Colloquium 24 – 'omics in risk assessment: state of the art and next steps , 2018, EFSA Supporting Publications.

[11]  Russell S. Thomas,et al.  BMDExpress Data Viewer ‐ a visualization tool to analyze BMDExpress datasets , 2015, Journal of applied toxicology : JAT.

[12]  Doug Crump,et al.  Transcriptomic points-of-departure from short-term exposure studies are protective of chronic effects for fish exposed to estrogenic chemicals. , 2019, Toxicology and applied pharmacology.

[13]  Vittorio Fortino,et al.  eUTOPIA: solUTion for Omics data PreprocessIng and Analysis , 2018, bioRxiv.

[14]  Bruce C Allen,et al.  BMDExpress: a software tool for the benchmark dose analyses of genomic data , 2007, BMC Genomics.

[15]  S. Jo,et al.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications. , 2011, Journal of proteomics.

[16]  T. Teräsvirta,et al.  Model selection criteria and model selection tests in regression models , 1986 .

[17]  Anders Wallqvist,et al.  Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney , 2018, Front. Pharmacol..

[18]  Angela Serra,et al.  BMDx: a graphical Shiny application to perform Benchmark Dose analysis for transcriptomics data , 2020, Bioinform..

[19]  Andrew Williams,et al.  Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes , 2015, Particle and Fibre Toxicology.

[20]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2017 , 2016, Nucleic Acids Res..

[21]  Hiroshi Yamada,et al.  Open TG-GATEs: a large-scale toxicogenomics database , 2014, Nucleic Acids Res..

[22]  S. Matsuda,et al.  Mechanisms of action of cyclosporine. , 2000, Immunopharmacology.

[23]  Teresa Lettieri,et al.  Recent Applications of DNA Microarray Technology to Toxicology and Ecotoxicology , 2005, Environmental health perspectives.

[24]  A. Ragab,et al.  Cyclosporine Toxicity and Toxicokinetics Profiles in Renal TransplantRecipients , 2013 .

[25]  Kevin C. Dorff,et al.  The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models , 2010, Nature Biotechnology.

[26]  Angela Serra,et al.  FunMappOne: a tool to hierarchically organize and visually navigate functional gene annotations in multiple experiments , 2019, BMC Bioinformatics.

[27]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[28]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[29]  Jeffery A Engelhardt,et al.  The no-observed-adverse-effect-level in drug safety evaluations: use, issues, and definition(s). , 2005, Regulatory toxicology and pharmacology : RTP.